First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

por Yap, T A, Cortes-Funes, H, Shaw, H, Rodriguez, R, Olmos, D, Lal, R, Fong, P C, Tan, D S, Harris, D, Capdevila, J, Coronado, C, Alfaro, V, Soto-Matos, A, Fernández-Teruel, C, Siguero, M, Tabernero, J M, Paz-Ares, L, de Bono, J S, López-Martin, J A
Publicado 2012

Use of Aspirin postdiagnosis improves survival for colon cancer patients

por Bastiaannet, E, Sampieri, K, Dekkers, O M, de Craen, A J M, van Herk-Sukel, M P P, Lemmens, V, van den Broek, C B M, Coebergh, J W, Herings, R M C, van de Velde, C J H, Fodde, R, Liefers, G J
Publicado 2012

Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort

por Grote, V A, Kaaks, R, Nieters, A, Tjønneland, A, Halkjær, J, Overvad, K, Skjelbo Nielsen, M R, Boutron-Ruault, M C, Clavel-Chapelon, F, Racine, A, Teucher, B, Becker, S, Pischon, T, Boeing, H, Trichopoulou, A, Cassapa, C, Stratigakou, V, Palli, D, Krogh, V, Tumino, R, Vineis, P, Panico, S, Rodríguez, L, Duell, E J, Sánchez, M-J, Dorronsoro, M, Navarro, C, Gurrea, A B, Siersema, P D, HM Peeters, P, Ye, W, Sund, M, Lindkvist, B, Johansen, D, Khaw, K-T, Wareham, N, Allen, N E, Travis, R C, Fedirko, V, Jenab, M, Michaud, D S, Chuang, S-C, Romaguera, D, Bueno-de-Mesquita, H B, Rohrmann, S
Publicado 2012

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast can...

por Mohammed, Z MA, Going, J J, Edwards, J, Elsberger, B, Doughty, J C, McMillan, D C
Publicado 2012

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

por Hofheinz, R-D, Heinemann, V, von Weikersthal, L F, Laubender, R P, Gencer, D, Burkholder, I, Hochhaus, A, Stintzing, S
Publicado 2012

The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium

por Felix, A S, Cook, L S, Gaudet, M M, Rohan, T E, Schouten, L J, Setiawan, V W, Wise, L A, Anderson, K E, Bernstein, L, De Vivo, I, Friedenreich, C M, Gapstur, S M, Goldbohm, R A, Henderson, B, Horn-Ross, P L, Kolonel, L, Lacey, J V, Liang, X, Lissowska, J, Magliocco, A, McCullough, M L, Miller, A B, Olson, S H, Palmer, J R, Park, Y, Patel, A V, Prescott, J, Rastogi, R, Robien, K, Rosenberg, L, Schairer, C, Ou Shu, X, van den Brandt, P A, Virkus, R A, Wentzensen, N, Xiang, Y-B, Xu, W-H, Yang, H P, Brinton, L A
Publicado 2013

Common genetic variants in the 9p21 region and their associations with multiple tumours

por Gu, F, Pfeiffer, R M, Bhattacharjee, S, Han, S S, Taylor, P R, Berndt, S, Yang, H, Sigurdson, A J, Toro, J, Mirabello, L, Greene, M H, Freedman, N D, Abnet, C C, Dawsey, S M, Hu, N, Qiao, Y-L, Ding, T, Brenner, A V, Garcia-Closas, M, Hayes, R, Brinton, L A, Lissowska, J, Wentzensen, N, Kratz, C, Moore, L E, Ziegler, R G, Chow, W-H, Savage, S A, Burdette, L, Yeager, M, Chanock, S J, Chatterjee, N, Tucker, M A, Goldstein, A M, Yang, X R
Publicado 2013

Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer

por Chow, L W-C, Xu, B, Gupta, S, Freyman, A, Zhao, Y, Abbas, R, Vo Van, M-L, Bondarenko, I
Publicado 2013

Multicentre external validation of IOTA prediction models and RMI by operators with varied training

por Sayasneh, A, Wynants, L, Preisler, J, Kaijser, J, Johnson, S, Stalder, C, Husicka, R, Abdallah, Y, Raslan, F, Drought, A, Smith, A A, Ghaem-Maghami, S, Epstein, E, Van Calster, B, Timmerman, D, Bourne, T
Publicado 2013

Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas

por Ivanov, S V, Panaccione, A, Nonaka, D, Prasad, M L, Boyd, K L, Brown, B, Guo, Y, Sewell, A, Yarbrough, W G
Publicado 2013

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

por Bellone, S, Tassi, R, Betti, M, English, D, Cocco, E, Gasparrini, S, Bortolomai, I, Black, J D, Todeschini, P, Romani, C, Ravaggi, A, Bignotti, E, Bandiera, E, Zanotti, L, Pecorelli, S, Ardighieri, L, Falchetti, M, Donzelli, C, Siegel, E R, Azodi, M, Silasi, D-A, Ratner, E, Schwartz, P E, Rutherford, T J, Santin, A D
Publicado 2013

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

por Bamias, A, Tzannis, K, Beuselinck, B, Oudard, S, Escudier, B, Diosynopoulos, D, Papazisis, K, Lang, H, Wolter, P, de Guillebon, E, Stravodimos, K, Chrisofos, M, Fountzilas, G, Elaidi, R-T, Dimopoulos, M A, Bamia, C
Publicado 2013

EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy

por Kumai, T, Matsuda, Y, Oikawa, K, Aoki, N, Kimura, S, Harabuchi, Y, Celis, E, Kobayashi, H
Publicado 2013

Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy

por Chang, K-C, Wu, Y-Y, Hung, C-H, Lu, S-N, Lee, C-M, Chiu, K-W, Tsai, M-C, Tseng, P-L, Huang, C-M, Cho, C-L, Chen, H-H, Hu, T-H
Publicado 2013

The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis

por Zhang, S S, Yang, H, Luo, K J, Huang, Q Y, Chen, J Y, Yang, F, Cai, X L, Xie, X, Liu, Q W, Bella, A E, Hu, R G, Wen, J, Hu, Y, Fu, J H
Publicado 2013

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

por Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P
Publicado 2013

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study

por Copson, E, Maishman, T, Gerty, S, Eccles, B, Stanton, L, Cutress, R I, Altman, D G, Durcan, L, Simmonds, P, Jones, L, Tapper, W, Eccles, Diana
Publicado 2014

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling

por Wang, L-H, Li, Y, Yang, S-N, Wang, F-Y, Hou, Y, Cui, W, Chen, K, Cao, Q, Wang, S, Zhang, T-Y, Wang, Z-Z, Xiao, W, Yang, J-Y, Wu, C-F
Publicado 2014

Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database

por Neal, R D, Din, N U, Hamilton, W, Ukoumunne, O C, Carter, B, Stapley, S, Rubin, G
Publicado 2014

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a r...

por Wevers, M R, Aaronson, N K, Verhoef, S, Bleiker, E M A, Hahn, D E E, Kuenen, M A, van der Sanden-Melis, J, Brouwer, T, Hogervorst, F B L, van der Luijt, R B, Valdimarsdottir, H B, van Dalen, T, Theunissen, E B M, van Ooijen, B, de Roos, M A, Borgstein, P J, Vrouenraets, B C, Vriens, E, Bouma, W H, Rijna, H, Vente, J P, Witkamp, A J, Rutgers, E J T, Ausems, M G E M
Publicado 2014